The stabilities of eight strains of respiratory syncytial virus were compared after the strains were freeze-dried in the presence and absence of the stabilizer SPGA, which contains 218 mM sucrose, 7.1 mM dipotassium hydrogen phosphate, 3.76 mM potassium dihydrogen phosphate, 4.9 mM sodium glutamate, and 1 % (wt/vol) bovine albumin. Strains freeze-dried in the presence of SPGA showed only small-to-negligible losses at 4°C and losses of approximately 2.0 1glo infectious units at 25°C when held for 45 weeks. Losses at 37°C for one strain were approximately 10-fold greater when the strain was freeze-dried in the absence of SPGA. These results indicate that respiratory syncytial virus strains freeze-dried in the presence of a suitable stabilizer can be transported as unrefrigerated samples without undue losses in infectivity.
Respiratory syncytial virus (RSV) is the major cause of bronchiolitis and pneumonia in young children. Its significance has been recognized by the World Health Organization in the Program for Vaccine Development, which inter alia calls for new initiatives in the prophylaxis of acute viral respiratory diseases of childhood, including those induced by RSV.
RSV isolates are difficult to handle in the laboratory. They are highly cell associated, grow only to relatively low titer in cell culture, and are extremely susceptible to loss of potency after freezing and thawing. Accordingly, the transportation of reference strains between laboratories is difficult unless elaborate precautions are taken to maintain levels of dry ice or liquid nitrogen in storage containers.
Because inactivated vaccines do not provide protection against RSV (6) , several attempts have been made to develop living attenuated vaccines for direct administration to the respiratory tract (9, 10) . No satisfactory vaccine is available, but even if it were, problems in distribution to areas of the world dependent on the "cold chain" would still exist.
Many labile enveloped viruses, such as coronaviruses, parainfluenza virus 4, and mumps virus, have been stabilized by freeze-drying, thereby allowing transport of reference strains with minimal refrigeration or even unrefrigerated through the mail. Many live virus vaccines used in both human and veterinary medicine have been freeze-dried and found to remain potent when reconstituted under field conditions (2, 4, 7, 8) . Stabilized freeze-dried yellow fever virus vaccines, in particular, are suitable for use in tropical countries (2) . Some years ago, a parenterally administered freeze-dried live vaccine for use against RSV was described (3). The vaccine consisted of a virus preparation that had been grown in a diploid cell line and freeze-dried, but no details as to its stability were reported (3). Experience from several other laboratories has indicated that RSV strains are difficult to freeze-dry. We studied the stability of an RSV strain after freeze-drying in the presence or absence of the * Corresponding author.
stabilizer SPGA (1, 4) and determined the long-term stability of several strains freeze-dried in the presence of SPGA.
Seven strains ( 1% (wt/vol) bovine albumin. To prepare stabilized samples for freeze-drying, the supernatant fluid of infected cells from each flask was decanted and replaced with an equal volume (10 ml) of SPGA. Infected celîs were then scraped from the surface of the flask, partly disaggregated by pipetting, and transferred to a conical centrifuge tube for further disaggregation with a vortex mixer. To prepare unstabilized samples, infected cells were removed in the same manner and suspended in the maintenance medium used for virus culture (medium 199 with 2% fetal bovine serum). Samples (0.5 ml) from either suspension were added to ampoules for freezedrying. The total protein content of each ampoule was approximately 500 ,tg.
Freeze-drying was done with a Dynavac freeze-dryer (model FD2; Dynavac Pty. Ltd., Boronia, Victoria, Australia) for 14 h at a final working pressure of 0.13 torr. After this time, there was no rise in pressure after the ice condenser was shut off, indicating that the main drying phase had been completed. Dried nitrogen was introduced to the drying chamber, and each ampoule was heat sealed and stored at -800C.
The infectivity titers of virus present after storage were determined by a plaque assay in monolayers of the CV-1 cell line. Two-day monolayer cultures in 6-well plates (Costar, Cambridge, Mass.) were inoculated with 0.1-ml dilutions of virus suspensions. Adsorption was for 1 h at 22°C, during which the monolayers were constantly rocked to distribute the inoculum. The plates were then washed with phosphatebuffered saline, and 3 ml of a nutrient overlay was added at 45°C. The nutrient overlay consisted of Leibovitz medium with 5% fetal bovine serum, 0.028% (wt/vol) NaHCO3, 0.01 M HEPES buffer (N-2-hydroxyethylpiperazine-N'-2-ethane-J. CLIN. MICROBIOL. M-714, R-191, PN-18 , and M-1009) suggest that only small losses in infectivity occur as a result of freeze-drying; in some instances, the titer, after reconstitution of material held at -80°C, was actually higher than that of the stabilized non-freeze-dried preparation, suggesting that disaggregation of clumped particles occurred after reconstitution of the freeze-dried material. Similar findings have been noted for herpesvirus of turkeys and varicella-zoster virus. Sucrose has been shown to be the essential component of SPGA for preserving the virion structure and infectivity of varicella-zoster virus and has also been shown to be necessary to preserve the infectivity of yellow fever virus and rickettsiae (1, 5; G. A. Tannock, unpublished observations). For varicella-zoster virus, increased stability was associated with a higher moisture content in the freeze-dried pellet containing sucrose, but precisely how this contributes to membrane stability remains unclear. Because SPGA was not toxic for CV-1 cells, reconstituted virus can be repropagated without reducing the concentration of stabilizer by dilution or gel filtration.
Overall, these results suggest that preparations of RSV freeze-dried in the presence of SPGA are relatively stable. Reference strains prepared in this manner have been transported between laboratories by mail without refrigeration and have remained infectious. Live vaccines prepared in the same manner could also be expected to show relatively small infectivity losses after 12 months if held at 4°C, which would greatly assist in their distribution.
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